373 related articles for article (PubMed ID: 24325868)
21. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
22. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.
Ozen M; Ittmann M
Clin Cancer Res; 2005 Jul; 11(13):4701-6. PubMed ID: 16000564
[TBL] [Abstract][Full Text] [Related]
23. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.
Sisinni L; Maddalena F; Condelli V; Pannone G; Simeon V; Li Bergolis V; Lopes E; Piscazzi A; Matassa DS; Mazzoccoli C; Nozza F; Lettini G; Amoroso MR; Bufo P; Esposito F; Landriscina M
J Pathol; 2017 Sep; 243(1):123-134. PubMed ID: 28678347
[TBL] [Abstract][Full Text] [Related]
24. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
25. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
[TBL] [Abstract][Full Text] [Related]
26. Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells.
Urrego D; Movsisyan N; Ufartes R; Pardo LA
Cell Cycle; 2016; 15(6):799-811. PubMed ID: 27029528
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
[TBL] [Abstract][Full Text] [Related]
28. Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells.
Qiao L; Zheng J; Tian Y; Zhang Q; Wang X; Chen JJ; Zhang W
Cell Death Dis; 2018 May; 9(6):583. PubMed ID: 29789527
[TBL] [Abstract][Full Text] [Related]
29. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
31. Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells.
Ou TT; Wang CJ; Lee YS; Wu CH; Lee HJ
Mol Nutr Food Res; 2010 Dec; 54(12):1781-90. PubMed ID: 20564478
[TBL] [Abstract][Full Text] [Related]
32. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
[TBL] [Abstract][Full Text] [Related]
36. Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.
Herman-Antosiewicz A; Kim YA; Kim SH; Xiao D; Singh SV
Pharm Res; 2010 Jun; 27(6):1072-9. PubMed ID: 20143254
[TBL] [Abstract][Full Text] [Related]
37. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
38. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
Chang MM; Lai MS; Hong SY; Pan BS; Huang H; Yang SH; Wu CC; Sun HS; Chuang JI; Wang CY; Huang BM
Cancer Sci; 2018 Nov; 109(11):3503-3518. PubMed ID: 30191630
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
40. Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis.
Wang T; Xie ZP; Huang ZS; Li H; Wei AY; Di JM; Xiao HJ; Zhang ZG; Cai LH; Tao X; Qi T; Chen DL; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):736-741. PubMed ID: 26489631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]